ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
다우존스 지수
42,732.13
0.80%
Bitcoin
98,322.82
0.12%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Turnstone Biologics Corporation (TSBX)

  7. Turnstone Biologics Corporation (TSBX) 뉴스

TSBX

Turnstone Biologics (TSBX)

Turnstone Biologics Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TSBX
일자시간출처헤드라인심볼기업
2024/11/1306:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
2024/11/1306:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/11/1306:05GlobeNewswire Inc.Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2024/11/0523:01GlobeNewswire Inc.Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
2024/10/1119:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/10/1119:00GlobeNewswire Inc.Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial RunwayNASDAQ:TSBXTurnstone Biologics Corporation
2024/10/0205:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/08/1505:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
2024/08/1505:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/08/1505:05GlobeNewswire Inc.Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2024/08/1505:01GlobeNewswire Inc.Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal CancerNASDAQ:TSBXTurnstone Biologics Corporation
2024/06/0606:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/06/0105:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406:01GlobeNewswire Inc.Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2024/05/0822:00GlobeNewswire Inc.Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
2024/04/1622:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:TSBXTurnstone Biologics Corporation
2024/03/2206:06GlobeNewswire Inc.Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2024/03/0522:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/02/2120:00GlobeNewswire Inc.Turnstone Biologics to Participate in Upcoming Investor ConferencesNASDAQ:TSBXTurnstone Biologics Corporation
2024/02/2107:00GlobeNewswire Inc.Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.NASDAQ:TSBXTurnstone Biologics Corporation
2023/11/2720:00GlobeNewswire Inc.Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
2023/11/1011:49GlobeNewswire Inc.Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2023/11/0319:00GlobeNewswire Inc.Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/3019:00GlobeNewswire Inc.Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. WeberNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
 검색 관련기사 보기:NASDAQ:TSBX

최근 히스토리

USOTC
RHHBY
Roche (QX)
NASDAQ
AAPL
Apple
COIN
BTCUSD
Bitcoin
FX
USDGBP
US Dollar vs Sterling
NYSE
VZ
Verizon Communications
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
FX
USDEUR
US Dollar vs Euro
NASDAQ
NVDA
NVIDIA
COIN
ADAUSD
Cardano
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
DOGEUSD
Dogecoin
NASDAQ
GOOGL
Alphabet
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유